Teachers Advisors’s Altimmune ALT Stock Holding History

Teachers Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-324	Closed	-$79K	–	3125
2017 Q1	$79K	Hold	324	–	–	﹤0.01%	3000
2016 Q4	$316K	Hold	324	–	–	﹤0.01%	2754
2016 Q3	$282K	Hold	324	–	–	﹤0.01%	2737
2016 Q2	$237K	Buy	+324	New	+$222K	﹤0.01%	2802

Other funds holding ALT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Quadrant Glendale, California $18M AUM 24.2% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Teachers Advisors's ALT Position: Q2 2017 in Review

Teachers Advisors sold out of Altimmune (ALT) in Q2 2017, closing a stake of 324 shares — an estimated $79K sold.

Teachers Advisors first reported a position in ALT in Q2 2016 and held it in 4 quarters. The position peaked at $316K in Q4 2016. 41 funds tracked by Wall St. Rank hold ALT as of Q2 2017.

Teachers Advisors reported no remaining Altimmune position as of Q2 2017 after selling out during the quarter.
Teachers Advisors sold 324 Altimmune shares in Q2 2017, an estimated $79K.
Teachers Advisors first reported a position in Altimmune in Q2 2016 and held it in 4 quarters.
Teachers Advisors's Altimmune position peaked at $316K in Q4 2016.
41 funds tracked by Wall St. Rank held Altimmune as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.